Sunday, September 18, 2016 6:22:35 PM
Estimated annual cost savings in 2016 for Glatopa 20 mg
versus the daily COPAXONE 20 mg dose is ~$17k per patient
based on US wholesale acquisition costs
http://files.shareholder.com/downloads/MNTA/2590681078x0x907661/F0EBE260-7F36-4535-BAB7-698E8C39F96A/MNTA_Wells_Fargo_Conf_9.9.16.pdf
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM